Pfizer leans on confidential peer review :The Scientist [22nd February 2008]

Supplements

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

Institutions

For Advertisers

Bookmark & Share

Del.icio.us

Digg

Facebook

Google

Twitter

Stumble it!

Yahoo!

Printer friendly version

Email to a friend

Close Window

News:

Pfizer leans on confidential peer review

Posted by Andrea Gawrylewski

[Entry posted at 22nd February 2008 09:19 PM GMT]

Comment on this news story

The sanctity of peer review is under scrutiny again.

Last month Pfizer filed a motion in federal court to force the New England Journal of Medicine to turn over confidential peer review documents for two of their products, Celebrex and Bextra. The ...

For FREE access to this news story and more, you must register.


	The article you are attempting to read is only available to registered users of The Scientist. Registration is FREE and only takes a few seconds.

Create your MyScientist account and access all of The Scientist's free content, tools and life science email newsletters, including:

> The current month’s print issue

> Daily & Bi-weekly e-mail newsletters

> Newsblogs with breaking headlines

> The Scientist Community

> Exclusive web extras

> The Scientist Careers

Premium content from The Scientist Archive, a comprehensive resource of over 22 years of past life science coverage, is available only by subscription. Subscribe today and get unlimited access